Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-23-039352
Filing Date
2023-06-23
Accepted
2023-06-23 16:16:12
Documents
1
Period of Report
2023-06-21

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4123
  Complete submission text file 0001209191-23-039352.txt   5563
Mailing Address 175 WATER STREET NEW YORK NY 10038
Business Address
Dachille Douglas A. (Reporting) CIK: 0001652908 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38959 | Film No.: 231037873

Mailing Address 3160 PORTER DR. SUITE 250 PALO ALTO CA 94304
Business Address 3160 PORTER DR. SUITE 250 PALO ALTO CA 94304 (650) 391-9740
BridgeBio Pharma, Inc. (Issuer) CIK: 0001743881 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations